Are you Dr. Azziz-Baumgartner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1600 Clifton Rd Ne
Ms A32
Atlanta, GA 30329Phone+1 404-639-1744Fax+1 404-639-3866
Summary
- Dr. Eduardo Azziz-Baumgartner, MD is a board certified family physician in Atlanta, Georgia. He is currently licensed to practice medicine in Georgia.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Family Medicine, 1997 - 2000
University of Alabama School of MedicineClass of 1997
Certifications & Licensure
GA State Medical License 2005 - 2025- American Board of Family Medicine Family Medicine
Clinical Trials
- Bangladesh Secondary Transmission Handwashing Protocol Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- 8 citationsStudy of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocolAvital Hirsch, Mark A. Katz, Alon Peretz, David Greenberg, Rachael Wendlandt
BMC Infectious Diseases. 2018-11-06 - 4 citationsInfluenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.Mark G. Thompson, Giselle Soto, Alon Perez, Gabriella Newes-Adeyim, Young M. Yoo
Vaccine. 2021-09-09 - 66 citationsComparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled TrialBenjamin J. Cowling, Ranawaka A.P.M. Perera, Sophie A. Valkenburg, Nancy H. L. Leung, A. Danielle Iuliano
Clinical Infectious Diseases. 2020-10-23
Press Mentions
No Health Issues in Babies Whose Moms Got Flu Vaccine While PregnantJune 8th, 2021- As COVID Surge Wanes, California Faces Backlash over ‘Outrageous’ New RulesJanuary 27th, 2024
- COVID Variant JN.1 Is Not More Severe, Early CDC Data SuggestsJanuary 30th, 2024
